97 related articles for article (PubMed ID: 21682312)
1. Enzymatic probing of model lipid membranes: phospholipase A2 activity toward monolayers modified by oxicam NSAIDs.
Czapla K; Korchowiec B; Orlof M; Magnieto JR; Rogalska E
J Phys Chem B; 2011 Jul; 115(29):9290-8. PubMed ID: 21682312
[TBL] [Abstract][Full Text] [Related]
2. Differentiating oxicam nonsteroidal anti-inflammatory drugs in phosphoglyceride monolayers.
Czapla K; Korchowiec B; Rogalska E
Langmuir; 2010 Mar; 26(5):3485-92. PubMed ID: 20030324
[TBL] [Abstract][Full Text] [Related]
3. Meloxicam and meloxicam-beta-cyclodextrin complex in model membranes: effects on the properties and enzymatic lipolysis of phospholipid monolayers in relation to anti-inflammatory activity.
Wiecław K; Korchowiec B; Corvis Y; Korchowiec J; Guermouche H; Rogalska E
Langmuir; 2009 Feb; 25(3):1417-26. PubMed ID: 19123793
[TBL] [Abstract][Full Text] [Related]
4. A Langmuir monolayer study of the action of phospholipase A2 on model phospholipid and mixed phospholipid-GM1 ganglioside membranes.
Schulte W; Orlof M; Brand I; Korchowiec B; Rogalska E
Colloids Surf B Biointerfaces; 2014 Apr; 116():389-95. PubMed ID: 24524938
[TBL] [Abstract][Full Text] [Related]
5. Effect of lipid molecule headgroup mismatch on non steroidal anti-inflammatory drugs induced membrane fusion.
Mondal Roy S; Sarkar M
Langmuir; 2011 Dec; 27(24):15054-64. PubMed ID: 21999838
[TBL] [Abstract][Full Text] [Related]
6. Interfacial approach to polyaromatic hydrocarbon toxicity: phosphoglyceride and cholesterol monolayer response to phenantrene, anthracene, pyrene, chrysene, and benzo[a]pyrene.
Korchowiec B; Corvis Y; Viitala T; Feidt C; Guiavarch Y; Corbier C; Rogalska E
J Phys Chem B; 2008 Oct; 112(43):13518-31. PubMed ID: 18834169
[TBL] [Abstract][Full Text] [Related]
7. [Possibilities of individual choice of NSAIDs on the example of the oxicam class, taking into account clinical and pharmacological characteristics].
Putilina MV; Teplova NV
Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(7):36-41. PubMed ID: 35904290
[TBL] [Abstract][Full Text] [Related]
8. Differential Effect of Oxicam Non-Steroidal Anti-Inflammatory Drugs on Membranes and Their Consequence on Membrane Fusion.
Majumdar A; Kundu D; Sarkar M
J Phys Chem B; 2015 Jul; 119(30):9627-39. PubMed ID: 26147344
[TBL] [Abstract][Full Text] [Related]
9. A biophysical approach to phospholipase A2 activity and inhibition by anti-inflammatory drugs.
Gaspar D; Lúcio M; Wagner K; Brezesinski G; Rocha S; Costa Lima JL; Reis S
Biophys Chem; 2010 Nov; 152(1-3):109-17. PubMed ID: 20846779
[TBL] [Abstract][Full Text] [Related]
10. Membrane fusion: a new function of non steroidal anti-inflammatory drugs.
Chakraborty H; Mondal S; Sarkar M
Biophys Chem; 2008 Sep; 137(1):28-34. PubMed ID: 18617319
[TBL] [Abstract][Full Text] [Related]
11. Oxicams, a class of nonsteroidal anti-inflammatory drugs and beyond.
Xu S; Rouzer CA; Marnett LJ
IUBMB Life; 2014 Dec; 66(12):803-11. PubMed ID: 25537198
[TBL] [Abstract][Full Text] [Related]
12. Interaction of Oxicam NSAIDs with lipid monolayer: anomalous dependence on drug concentration.
Kundu S; Chakraborty H; Sarkar M; Datta A
Colloids Surf B Biointerfaces; 2009 Apr; 70(1):157-61. PubMed ID: 19157803
[TBL] [Abstract][Full Text] [Related]
13. Interaction of oxicam NSAIDs with DMPC vesicles: differential partitioning of drugs.
Chakraborty H; Roy S; Sarkar M
Chem Phys Lipids; 2005 Dec; 138(1-2):20-8. PubMed ID: 16183046
[TBL] [Abstract][Full Text] [Related]
14. Interactions of a fungistatic antibiotic, griseofulvin, with phospholipid monolayers used as models of biological membranes.
Corvis Y; Barzyk W; Brezesinski G; Mrabet N; Badis M; Hecht S; Rogalska E
Langmuir; 2006 Aug; 22(18):7701-11. PubMed ID: 16922553
[TBL] [Abstract][Full Text] [Related]
15. Prevention of cytokine-induced changes in leukocyte adhesion receptors by nonsteroidal antiinflammatory drugs from the oxicam family.
García-Vicuña R; Díaz-González F; González-Alvaro I; del Pozo MA; Mollinedo F; Cabañas C; González-Amaro R; Sánchez-Madrid F
Arthritis Rheum; 1997 Jan; 40(1):143-53. PubMed ID: 9008610
[TBL] [Abstract][Full Text] [Related]
16. Spectroscopic studies of the binding of Cu(II) complexes of oxicam NSAIDs to alternating G-C and homopolymeric G-C sequences.
Chakraborty S; Bose M; Sarkar M
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Mar; 122():690-7. PubMed ID: 24345609
[TBL] [Abstract][Full Text] [Related]
17. Membrane activity of tetra-p-guanidinoethylcalix[4]arene as a possible reason for its antibacterial properties.
Sautrey G; Orlof M; Korchowiec B; de Vains JB; Rogalska E
J Phys Chem B; 2011 Dec; 115(50):15002-12. PubMed ID: 22081973
[TBL] [Abstract][Full Text] [Related]
18. Effects of gemini amphiphilic pseudopeptides on model lipid membranes: a Langmuir monolayer study.
Rubio-Magnieto J; Luis SV; Orlof M; Korchowiec B; Sautrey G; Rogalska E
Colloids Surf B Biointerfaces; 2013 Feb; 102():659-66. PubMed ID: 23107944
[TBL] [Abstract][Full Text] [Related]
19. Photophysical studies of oxicam group of NSAIDs: piroxicam, meloxicam and tenoxicam.
Banerjee R; Chakraborty H; Sarkar M
Spectrochim Acta A Mol Biomol Spectrosc; 2003 Apr; 59(6):1213-22. PubMed ID: 12659890
[TBL] [Abstract][Full Text] [Related]
20. Effects of lornoxicam, piroxicam, and meloxicam in a model of thermal hindpaw hyperalgesia induced by formalin injection in rat tail.
Bianchi M; Panerai AE
Pharmacol Res; 2002 Feb; 45(2):101-5. PubMed ID: 11846620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
